LifeClean International AB (LCLEAN) AI Stock Analysis

• Market Cap: €39.75M
• Dividend Yield: N/A
• Average Volume (3M): 529.05K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.54
• Revenue Growth: -3.09%
• EPS Growth: 29.52%
• Country: SE
• Employees: 31
• Sector: Consumer Defensive
• Sector Strength: 56
• Industry: Household & Personal Products
• EPS (TTM): -0.03
• Shares Outstanding: 274,110,400
• 10 Day Avg. Volume: 362,461
• 30 Day Avg. Volume: 529,053
• PEG Ratio: -0.02
• Price to Book (P/B): -1.07
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -1.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0

• Rating: 39 Underperform
• Price Target: kr0.00 ▼(-100.00%Downside)

LifeClean International AB's stock score is primarily impacted by its poor financial performance, reflecting severe financial instability across income statements, balance sheets, and cash flows. The technical analysis indicates bearish trends, while the negative P/E ratio and lack of dividend yield highlight valuation challenges. The overall outlook is concerning, warranting caution for potential investors.

LifeClean International AB Business Overview & Revenue Model

Company Description

LifeClean International AB (LCLEAN) is a Swedish company specializing in the development, production, and distribution of advanced disinfection solutions. The company operates primarily in the healthcare, public health, and industrial sectors, providing highly effective and environmentally friendly disinfection products. LifeClean's core product offerings include surface disinfectants that are designed to eliminate a wide range of pathogens, including bacteria, viruses, and fungi, thereby ensuring safer environments for its clients.

How the Company Makes Money

LifeClean International AB generates revenue primarily through the sale of its disinfection products. The company's key revenue streams include direct sales to healthcare facilities, industrial clients, and public institutions that require high-level sanitation solutions. Additionally, LifeClean may engage in partnerships or distribution agreements with other organizations to expand its market reach. Factors contributing to its earnings include the growing demand for effective disinfection solutions in response to heightened awareness of hygiene and infection control, as well as regulatory requirements for sanitation in various sectors. By leveraging its expertise in producing innovative and sustainable disinfection products, LifeClean maintains a competitive position in the market, which supports its financial performance.

LifeClean International AB Financial Statement Overview

Summary

LifeClean International AB is experiencing severe financial difficulties across all major financial statements. The income statement reflects declining revenues and significant losses. The balance sheet shows negative equity, indicating financial distress and high liabilities. Cash flow challenges further exacerbate instability, highlighting urgent needs for restructuring and improved efficiency.

Income Statement

LifeClean International AB shows a concerning financial trajectory with declining revenues and negative profit margins. The TTM data indicates a net loss with a net profit margin of -79.7%, and gross profit margin of 10.9%, which is weak compared to industry standards. Revenue has decreased by 1.7% compared to the previous year, and EBIT and EBITDA margins are also negative, indicating operational inefficiencies.

Balance Sheet

The balance sheet presents significant financial instability. With a negative stockholders' equity of SEK -12.43 million in TTM, the company faces financial distress risks. The debt-to-equity ratio is not applicable due to negative equity, and the equity ratio is also negative, indicating more liabilities than assets. This suggests high leverage and potential solvency issues.

Cash Flow

Cash flow analysis reveals critical challenges with negative operating and free cash flows. The TTM free cash flow stands at SEK -37.08 million, worsening from the previous period. The operating cash flow to net income ratio is not favorable, underscoring ongoing cash management issues. Financing activities are primarily sustaining operations, a risky strategy in the long term.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	61.15M	52.50M	47.18M	53.36M	31.79M
Gross Profit	26.82M	22.77M	19.52M	-30.81M	24.04M
EBITDA	-40.87M	-32.39M	-27.79M	-26.05M	395.00K
Net Income	-53.72M	-44.24M	-36.09M	-32.75M	-3.48M
Balance Sheet
Total Assets	61.80M	68.61M	76.37M	82.59M	76.47M
Cash, Cash Equivalents and Short-Term Investments	10.57M	8.29M	11.61M	8.85M	42.45M
Total Debt	44.90M	47.84M	32.38M	18.54M	4.45M
Total Liabilities	65.43M	67.29M	62.56M	32.70M	11.53M
Stockholders Equity	-3.63M	1.31M	13.81M	49.89M	64.94M
Cash Flow
Free Cash Flow	-42.66M	-39.99M	-20.07M	-23.01M	-12.49M
Operating Cash Flow	-40.83M	-35.46M	-16.96M	-21.79M	-5.09M
Investing Cash Flow	-1.85M	-4.54M	-3.13M	-36.51M	-7.81M
Financing Cash Flow	44.96M	36.67M	22.84M	24.68M	52.90M

LifeClean International AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.14
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LCLEAN, the sentiment is Negative. The current price of 0.14 is below the 20-day moving average (MA) of 0.15, below the 50-day MA of 0.18, and below the 200-day MA of 0.87, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 35.09 is Neutral, neither overbought nor oversold. The STOCH value of 5.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LCLEAN.

LifeClean International AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLEM	68 Neutral	kr131.54M	16.46	7.04%	―	-6.04%	-38.05%
POLYG	64 Neutral	kr471.20M	28.16	-4.31%	2.17%	35.99%	95.51%
Sector *	63 Neutral	kr24.74B	13.72	52.46%	3.80%	8.70%	-20.50%
DUNI	61 Neutral	kr4.39B	19.82	6.56%	5.36%	2.62%	-40.22%
LCLEAN	39 Underperform	€39.75M	―	-598.14%	―	-3.09%	29.52%
QLIFE	33 Underperform	kr49.94M	―		―	-63.52%	93.00%